M e d i c i n e A v e n u e Client: Merck. Agency: FCB Healthcare. CD: Tom Domanico. AD/Designer: Julie Kenley. Copy: Liz Hevey. FOR MANY HYPERTENSIVE PATIENTS ONCE-A-DAY (ENALAPRIL MALEATE'MSD) THERAPY THAT MAY BE AS SILENT AS HYPERTENSION ITSELF VASOTEC*(Enalapril Maleate, MSD) is generally well tolerated and not characterized by certain undesirable effects associated with selected agents in other antihypertensive classes. \ASOTEC is contraindicated in patients who are hypersensitive to this product and in patients with a history of angoedema related to previous treatment with an AC6 inhibitor. A (SmWshed antihypertensive effect toward the end of the dosing interval can occur >nsome patients. For a 8nef Summary of Prescribing informatcn. please see the testpage of thisadvertisement Coo/right © 1989 by Merck & Co. Inc. 88
RkJQdWJsaXNoZXIy NDMwNDAx